1. Is HER2 Through?

   • George W. Sledge Jr.
   • Lida Mina
   • Anna Maria Storniolo

   Invited Commentary 30 June 2012 Pages: 169 - 170

2. Analysis of Cyclin D1 in Breast Cancer: A Call to Arms

   • Nicholas P. Tobin
   • Jonas Bergh

   Invited Commentary Open access 22 June 2012 Pages: 171 - 173

3. Options for Surgical Prophylaxis and Reconstruction

   • Benjamin J. Brown
   • Ali Al-Attar
   • Scott L. Spear

   Risk, Prevention, and Screening (MC Liu, Section Editor) 17 June 2012 Pages: 174 - 179

   

4. Comparison of Random Periareolar Fine Needle Aspirate versus Ductal Lavage for Risk Assessment and Prevention of Breast Cancer

   • Abigail Hoffman
   • Rod Pellenberg
   • Victoria Seewaldt

   Risk, Prevention, and Screening (MC Liu, Section Editor) Open access 22 June 2012 Pages: 180 - 187

   

5. Clinical Perspective: Influence of Modifiable Lifestyle Factors, Body Weight, Physical Activity, and Alcohol on Breast Cancer Outcome

   • Rowan T. Chlebowski

   Risk, Prevention, and Screening (MC Liu, Section Editor) 23 June 2012 Pages: 188 - 198

6. Prophylactic Mastectomy and Risk-Reducing Salpingo-oophorectomy in BRCA1/2 Mutation Carriers

   • Kara N. Maxwell
   • Susan M. Domchek

   Risk, Prevention, and Screening (MC Liu, Section Editor) 26 June 2012 Pages: 199 - 206

7. Tamoxifen versus Raloxifene versus Exemestane for Chemoprevention

   • Laura Reimers
   • Katherine D. Crew

   Risk, Prevention, and Screening (MC Liu, Section Editor) 26 June 2012 Pages: 207 - 215

   

8. Role of Mammography versus Magnetic Resonance Imaging for Breast Cancer Screening

   • Linei Urban
   • Cícero Urban

   Risk, Prevention, and Screening (MC Liu, Section Editor) 28 June 2012 Pages: 216 - 223